July 1, 2013
Bookmark and Share  
 
                 
  HCV
»
»
»
»

 

 

Greetings:

In June the United States Preventive Services Task Force (USPSTF) issued their report on testing for HCV and they graded testing at-risk populations and a one-time test for everyone born between 1945 and 1965 (Baby Boomers). The grade of ‘B’ for both means that the tests for HCV will be covered under the Affordable Care Act.  Maybe now that more people will be tested we will finally find out the true prevalence of HCV in the United States. 

This and many more important news stories in June.  To stay up to-date on the news and the drugs in development check out our Blog. 

Listed below are the latest and greatest postings to our websites.

Peace,

Alan

 

1. HCV Advocate Newsletter: July, 2013

In This Issue:

  • EASL 2013: DAAs Look Good, but Challenges Remain—Part 2 by Liz Highleyman. Liz continues her review of the data from EASL with an emphasis on the interferon add-on therapies some of which are likely to be the next standard of care for HCV treatment.

  • Snapshots by Lucinda K. Porter, RN. Snapshots is back! In this month's review Lucinda discusses the impact of the failed War on Drugs, knowledge of HCV and HIV/HCV coinfection, and the on-going quest to establish a true number of the HCV prevalence in the United States.

  • HEALTHWISE: Technically Speaking: Apps and Hepatitis C by Lucinda K. Porter, RN. The title says it all!

  • Myths about Weight Loss
    Alan Franciscus, Editor-in-Chief. Who doesn't know that a healthy weight is good for the liver; but there are a lot of myths about weight loss. Myths are dangerous and these myth busters will help. The truth is out there!

 

2. HBV Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B:

  • Experts Describe When to Treat Pregnant Women with Antivirals
  • Half of Patients Treated Long-Term with Tenofovir Lose HBeAg
  • Even Patients with High Viral Load Lose HBeAg with Tenofovir
  • New Type of Interferon Effective in Phase 2 Hepatitis B Trial
  • Majority of Hepatitis B Patients Have Vitamin D Deficiency
  • Patients with Healthy Vitamin D Levels Are More Likely to Clear HBsAg
  • Activists Develop a National Plan to Eradicate Hepatitis B in the U.S.
  • New Guidelines Urge Britain's Doctors to Improve Hepatitis B Care
  • Measuring HBsAg Levels May Identify Fibrosis and Avoid Liver Biopsies
  • HBsAg Levels May Also Predict Cancer Risk in HBeAg-negative Patients

 

3. Factsheets & Guides: New & Updated!

Be sure to check out our recently updated fact sheets and guides: Drug-Drug interactions (DDIs) are becoming even more important with the new direct acting antivirals. But the interactions are not confined to HCV treatment. Read our Easy C on DDIs.


What Are Drug Interactions?
Click Here

 

4. Clinical Trials Postings: Updated—June 17!
Be sure to check out the latest clinical trial postings at the HCV Advocate News & Pipeline Blog. Just click on the links to the Drug Companies at the top and to see which drugs are in trials right now, where the trials are, and how to register for one.

-----------------------------------

 

Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time.  For more information about the services they offer either call or visit their Website at www.help4hep.org  The helpline is run by The Support Partnership:  a group of non-profits working together to help people affected by hepatitis C. 

 

5. Top News (Blog) from the HCV Advocate News & Pipeline Blog includes: 

Top News

Hepatitis Threat Forces Another Frozen Fruit Recall
June 29

Jury to begin deliberating in hepatitis C case against ex-Vegas clinic owner, employee
June 28

77 hepatitis C cases reported in Okla. infection scandal
June 28

18 have hepatitis B after injections at SC clinic
June 28

GPs given 'key role' in improving hepatitis B
June 27

HCV triple therapy post-liver transplant yields moderate response, significant adverse events
June 27

Dietary Cholesterol Promotes Progression in Hepatitis C
June 26

Flu Shot Effective Regardless of Circulating Flu Strain, Research Finds
June 26

Aethlon Medical Announces FDA Approval of IDE to Treat Hepatitis C (HCV) Patients
June 25

New Type of Interferon Effective in Hepatitis B Trial
June 25

Hepatitis C Test for Baby Boomers Urged by Health Panel
June 24

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement
June 24

UAB Hospital Emergency Department to screen patients for hepatitis C
June 21

NH releases report on hepatitis C outbreak
June 21

State Legislature passes bill requiring doctors to offer hepatitis C tests to baby boomers
June 20

Idenix sees delay in human trials for hep C drug as FDA seeks more data
June 20

FDA Approves Abbott Test for Identifying Hepatitis C Genotypes
June 20

SVR more dependent on adherence to treatment duration than dosing interval
June 20

HHS Releases New Guideline to Reduce Disease Transmission Through Organ Transplantation
June 20

SVR after triple therapy maintained long-term durability in HCV patients
June 20

 

 

Follow us on Twitter
HCVAdvocate

———————————————

Join us on Facebook
Hcvadvocate Hcsp

 

 and much, much more…..

 

Sincerely,

Alan

Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org

**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org

**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.

 
  HBV
»
»
»